Idea principal
Pooling 12 trials in 878 adults with heart disease or hypertension, higher fibre intake lowered systolic blood pressure by 4.3 mmHg and diastolic by 3.1 mmHg in people with hypertension; in 3 cohorts of 7469 adults with heart disease, higher fibre intake was linked to lower all-cause mortality (RR 0.75). The mortality finding is observational and based on only three studies, and several other outcomes were rated low certainty.
Study design
Revisión de evidencia
Reading basis
Published abstract
Reading focus
Design & applicability
Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.
Pregunta de investigación
Eating more fibre is linked to a lower risk of developing cardiovascular disease (CVD) and lowers blood pressure, but it is not clear whether it adds benefit for people who already have CVD and take protective drugs. The authors reviewed the evidence for fibre as an add-on to treatment in people with CVD or hypertension.
Población y método
Systematic review and meta-analysis. Ovid MEDLINE, Embase, PubMed and CENTRAL were searched to June 2021. Eligible were prospective observational studies of fibre intake and mortality in people with existing CVD, and controlled trials of increased fibre on cardiometabolic risk factors in people with CVD or hypertension. Data were combined with random-effects models and dose-response analysis, and certainty of evidence was graded with GRADE. The review found 3 prospective studies (7469 adults with CVD) and 12 trials (878 adults with CVD or hypertension).
Resultados
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Higher fibre intake was associated with lower all-cause mortality in adults with CVD (relative risk 0.75, 95% CI 0.58-0.97), with moderate certainty evidence.
- 2In adults with hypertension, increasing fibre lowered systolic blood pressure by 4.3 mmHg (95% CI 2.2 to 5.8) and diastolic by 3.1 mmHg (95% CI 1.7 to 4.4), with high certainty evidence.
- 3In adults with CVD, low certainty evidence showed reductions in total cholesterol (mean difference -0.42 mmol/L, 95% CI -0.78 to -0.05) and LDL cholesterol (-0.47 mmol/L, 95% CI -0.85 to -0.10).
- 4Fasting blood glucose also improved (mean difference 0.48 mmol/L, 95% CI -0.91 to -0.05), with moderate or low certainty. The authors report benefits irrespective of cardioprotective drug use.
Límites e incertidumbre
- 1The mortality result rests on only 3 observational studies, so it cannot show that eating more fibre caused fewer deaths.
- 2Only 12 trials with 878 adults in total were pooled, and much of the evidence on cholesterol and glucose was graded low or moderate certainty.
- 3The abstract lists a second LDL cholesterol estimate (0.29 mmol/L, 95% CI 0.17 to 0.40) whose sign differs from the first, and does not explain which population it covers, so the LDL result should be read cautiously.
- 4The authors themselves say further trials and cohort analyses are needed to increase confidence.
Relevancia práctica
If you have high blood pressure or heart disease, getting more fibre from food is a reasonable addition to, not a replacement for, the treatment your clinician prescribes. The blood pressure drop was modest and the mortality link is not proof. Discuss any large change in diet with your clinician.
Tus datos
If you take blood pressure readings at home, use the same cuff, time of day and posture, and compare weekly averages before and after raising your fibre. A food log can show your average daily fibre intake, and changes are best judged over several weeks, not single readings.
Cómo interpretar la evidencia
Check which designs were included, how searches and bias assessment were conducted, and the last search date. Publication date alone does not make the underlying evidence current.
Resumen estructurado de los autores English
El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.
Background
Higher dietary fibre intakes are associated with a reduced risk of developing cardiovascular disease (CVD), and increasing intake has been shown to reduce blood pressure and other cardiometabolic risk factors. The extent to which dietary fibre can further reduce risk for those with CVD and treated with cardioprotective drugs has not been clearly established. We have examined the evidence for dietary fibre as adjunct therapy in those with CVD or hypertension.
Methods
Ovid MEDLINE, Embase, PubMed, and CENTRAL were searched to June 2021. Prospective observational studies reporting on fibre intakes and mortality in those with pre-existing CVD and controlled trials of increasing fibre intakes on cardiometabolic risk factors in those with CVD or hypertension were eligible. Outcomes were mortality (studies) and cardiometabolic risk factors (trials). Data synthesis was with random effects and dose response. Certainty of evidence was assessed using GRADE.
Results
Three prospective studies including 7469 adults with CVD, and 12 trials of 878 adults with CVD or hypertension were identified. Moderate certainty evidence indicates reduced all-cause mortality (relative risk, RR0.75 (95% confidence interval, CI 0.58-0.97)) when comparing higher with lower fibre intakes. Low certainty evidence from trials of adults with cardiovascular disease indicates increasing fibre intakes reduced total (mean difference, MD - 0.42 mmol/L (95%CI - 0.78 to - 0.05) and low-density lipoprotein (LDL) cholesterol (MD - 0.47mmol/L (95%CI - 0.85 to - 0.10)). High certainty evidence from trials of adults with hypertension indicates increasing fibre intakes reduces systolic (MD 4.3 mmHg (95% CI 2.2 to 5.8)) and diastolic blood pressure (MD 3.1 mmHg (95% CI 1.7 to 4.4)). Moderate and low certainty evidence indicated improvements in fasting blood glucose (MD 0.48 mmol/L (- 0.91 to - 0.05)) and LDL cholesterol (MD 0.29 mmol/L (95% CI 0.17 to 0.40)). Benefits were observed irrespective of cardioprotective drug use.
Conclusions
These findings emphasise the likely benefits of promoting greater dietary fibre intakes for patients with CVD and hypertension. Further trials and cohort analyses in this area would increase confidence in these results.
Fuentes y atribución
Dietary fibre in hypertension and cardiovascular disease management: systematic review and meta-analyses.
Reynolds AN, Akerman A, Kumar S, Diep Pham HT, Coffey S, Mann J.
BMC medicine · 2022-04-22
DOI: 10.1186/s12916-022-02328-x ↗PubMed · 35449060 ↗Europe PMC · Licencia registrada: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada
Fuentes verificadas 2026-11-01
Guías prácticas
Leer en contexto
Disrupted daily rest-activity rhythm is linked to higher mortality in 109,365 people
Across seven observational studies with 109,365 participants, a weaker day-night activity contrast (lower relative amplitude) was associated with higher cardiovascular mortality (hazard ratio [HR] 1.50, 95% CI 1.13 to 1.98) and all-cause mortality (HR 1.46, 95% CI 1.27 to 1.68). The evidence base is small and observational, so it cannot show that improving the rhythm lowers risk, and illness may itself disturb the rhythm.
Journal of the American Heart Association
Five exercise types lowered resting blood pressure, isometric training the most
Pooling 270 randomised trials with 15,827 participants, aerobic, resistance, combined, interval and isometric training all lowered resting blood pressure compared with non-intervention controls (P<0.001 for each), with the largest fall for isometric training: 8.24 mm Hg systolic and 4.00 mm Hg diastolic. The ranking between modes is partly indirect and the trials differ, so it is not a personal prescription.
British Journal of Sports Medicine
A salt substitute lowered stroke, major cardiovascular events and death in rural China
In 20,995 people in 600 rural Chinese villages who had a history of stroke or were 60 or older with high blood pressure, a salt substitute (75% sodium chloride, 25% potassium chloride) lowered the stroke rate versus regular salt over a mean 4.74 years: 29.14 versus 33.65 events per 1000 person-years (rate ratio 0.86, 95% CI 0.77 to 0.96; P = 0.006). Death was also lower (rate ratio 0.88) and serious hyperkalemia events were not significantly higher, but the trial was open-label and set in rural China.
The New England Journal of Medicine
Apple Watch irregular-pulse alerts were rare; 34% of those tested had atrial fibrillation
Among 419,297 Apple Watch users with no known atrial fibrillation (AF), 0.52% received an irregular-pulse alert, and 34% of the 450 who returned a usable ECG patch had AF (97.5% CI 29 to 39). Alerts that coincided with patch recording matched AF with a positive predictive value of 0.84 (95% CI 0.76 to 0.92), but only 20.8% of alerted people returned a patch and nobody without an alert was monitored, so a quiet watch does not rule AF out.
The New England Journal of Medicine

